trial · primary record
Psilocybin 25 mg
Early-stage Breast Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2031-08-31 |
| Primary endpoint | Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF) |
| Registry ID | NCT07909408 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:07.518Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07909408
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.